Novel therapies in pediatric rheumatic diseases.
Chira, Peter
Novel therapies in pediatric rheumatic diseases. [electronic resource] - Current opinion in pediatrics Dec 2003 - 579-85 p. digital
Publication Type: Journal Article; Review
1040-8703
10.1097/00008480-200312000-00007 doi
Anti-Inflammatory Agents, Non-Steroidal--therapeutic use
Antibodies, Monoclonal--therapeutic use
Antibodies, Monoclonal, Murine-Derived
Antirheumatic Agents--therapeutic use
Child
Genetic Therapy
Humans
Infliximab
Interleukin 1 Receptor Antagonist Protein
Isoxazoles--therapeutic use
Leflunomide
Methotrexate--therapeutic use
Mycophenolic Acid--analogs & derivatives
Neoplasm Proteins--therapeutic use
Receptors, Tumor Necrosis Factor, Type II
Rheumatic Diseases--genetics
Rituximab
Sialoglycoproteins--therapeutic use
Stem Cell Transplantation
Tumor Necrosis Factor Decoy Receptors
Novel therapies in pediatric rheumatic diseases. [electronic resource] - Current opinion in pediatrics Dec 2003 - 579-85 p. digital
Publication Type: Journal Article; Review
1040-8703
10.1097/00008480-200312000-00007 doi
Anti-Inflammatory Agents, Non-Steroidal--therapeutic use
Antibodies, Monoclonal--therapeutic use
Antibodies, Monoclonal, Murine-Derived
Antirheumatic Agents--therapeutic use
Child
Genetic Therapy
Humans
Infliximab
Interleukin 1 Receptor Antagonist Protein
Isoxazoles--therapeutic use
Leflunomide
Methotrexate--therapeutic use
Mycophenolic Acid--analogs & derivatives
Neoplasm Proteins--therapeutic use
Receptors, Tumor Necrosis Factor, Type II
Rheumatic Diseases--genetics
Rituximab
Sialoglycoproteins--therapeutic use
Stem Cell Transplantation
Tumor Necrosis Factor Decoy Receptors